Orchestra BioMed Holdings, Inc. Gain (Loss) on Investments
Orchestra BioMed Holdings, Inc. (OBIO) reported Gain (Loss) on Investments of -$68.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-03-12
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for the quarter ending 2024-12-31 was $0.00.
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for the quarter ending 2024-06-30 was -$23.00K.
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for the quarter ending 2024-03-31 was -$45.00K, a 421.43% decline year-over-year.
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for fiscal 2024 was -$68.00K.
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for fiscal 2023 was -$18.00K, a 101.75% decline from fiscal 2022.
- Orchestra BioMed Holdings, Inc. gain (loss) on investments for fiscal 2022 was $1.03M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$23.00K derived: sum of 3 quarters · filed 2026-03-12 | -$68.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$23.00K derived: sum of 2 quarters · filed 2025-11-10 | -$68.00K 10-Q · filed 2025-11-10 | -$362.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$23.00K 10-Q · filed 2025-08-12 | -$68.00K 10-Q · filed 2025-08-12 | -$362.00K derived: sum of 3 quarters · filed 2025-08-12 | -$69.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$45.00K 10-Q · filed 2025-05-12 | -$339.00K derived: sum of 2 quarters · filed 2025-05-12 | -$46.00K derived: sum of 3 quarters · filed 2025-05-12 | -$77.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.00K derived: sum of 2 quarters · filed 2025-03-31 | -$32.00K derived: sum of 3 quarters · filed 2025-03-31 | -$18.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $293.00K 10-Q · filed 2024-11-12 | $262.00K derived: sum of 2 quarters · filed 2024-11-12 | $276.00K 10-Q · filed 2024-11-12 | $111.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$31.00K 10-Q · filed 2024-08-12 | -$17.00K 10-Q · filed 2024-08-12 | -$182.00K derived: sum of 3 quarters · filed 2024-08-12 | -$496.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-13 | -$151.00K derived: sum of 2 quarters · filed 2024-05-13 | -$465.00K derived: sum of 3 quarters · filed 2024-05-13 | $1.26M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$479.00K derived: sum of 2 quarters · filed 2024-03-27 | $1.25M derived: sum of 3 quarters · filed 2024-03-27 | $1.03M 10-K · filed 2024-03-27 |
| 2022-09-30 | -$314.00K 10-Q · filed 2023-11-13 | $1.42M derived: sum of 2 quarters · filed 2023-11-13 | $1.20M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.73M 10-Q · filed 2023-08-10 | $1.51M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$220.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |